Konica Minolta Adds Ambry Genetics As First Piece Of Precision Medicine Business
Executive Summary
The $1bn deal, partly funded by the public/private Innovation Network Corporation of Japan, will create new diagnostic technologies for oncology and drug discovery, and bring a comprehensive genetic-diagnostic portfolio to Japan, among other markets.